Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments

被引：0
作者：
G. Grani
D. Tumino
V. Ramundo
L. Ciotti
C. Lomonaco
M. Armillotta
R. Falcone
P. Lucia
M. Maranghi
S. Filetti
C. Durante
机构：
[1] Sapienza University of Rome,Department of Translational and Precision Medicine
[2] University of Catania,Endocrinology, Department of Clinical and Experimental Medicine, Garibaldi
来源：
Journal of Endocrinological Investigation | 2019年 / 42卷
关键词：
Thyroid cancer; TSH variability; Levothyroxine dose adjustment; Real life; Hypothyroidism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1485 / 1490
页数：5
相关论文
共 50 条
  • [31] Changes in Thyroglobulin Antibody Levels in Differentiated Thyroid Cancer Patients After Thyroidectomy: A Retrospective Study in Basrah, Iraq
    Jebur, Mustafa M.
    Hussein, Ibrahim H.
    Alidrisi, Haider A.
    Mansour, Abbas A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [32] Effects of the Restoration of Euthyroidism After Chronic Suppressive Therapy With Levothyroxine in Patients With Thyroid Cancer
    Rosario, Pedro W.
    Borges, Michelle A.
    Purisch, Saido
    [J]. ENDOCRINOLOGIST, 2009, 19 (02) : 58 - 59
  • [33] Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
    Kinuya, Seigo
    Yokoyama, Kunihiko
    Michigisuh, Takatoshi
    Tonami, Norihisa
    [J]. ANNALS OF NUCLEAR MEDICINE, 2006, 20 (07) : 499 - 502
  • [34] Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
    Seigo Kinuya
    Kunihiko Yokoyama
    Takatoshi Michigishi
    Norihisa Tonami
    [J]. Annals of Nuclear Medicine, 2006, 20
  • [35] Benefits of basil tea for patients with differentiated thyroid cancer during radioiodine therapy: A randomized controlled trial
    Nomura, Kenta
    Nakayama, Michihiro
    Okizaki, Atsutaka
    [J]. HELIYON, 2023, 9 (10)
  • [36] The Assessment of Ventricular Arrhythmia Indicators Based on Electrocardiography in Patients With Differentiated Thyroid Cancer Followed Up With Levothyroxine Suppression
    Hepsen, Sema
    Sakiz, Davut
    Pamukcu, Hilal Erken
    Arslan, Ismail Emre
    Duger, Hakan
    Akhanli, Pinar
    Sencar, Muhammed Erkam
    Unsal, Ilknur Ozturk
    Ucan, Bekir
    Kizilgul, Muhammed
    Cakal, Erman
    [J]. ANGIOLOGY, 2021, 72 (07) : 657 - 663
  • [37] Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma
    De Melo T.G.
    Da Assumpção L.V.M.
    Santos A.D.O.
    Zantut-Wittmann D.E.
    [J]. Thyroid Research, 8 (1)
  • [38] Is there any venous gradient in serum thyroglobulin levels in patients with differentiated thyroid cancer?
    Gulben, K.
    Berberoglu, U.
    Uluocak, A.
    [J]. NEOPLASMA, 2010, 57 (03) : 260 - 263
  • [39] Gender, FT4 levels, T stage, and BMI as predictors of TSH levels in thyroid cancer patients
    Zhang, Sen
    Niu, Shuli
    Zhou, Ling
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [40] Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer
    Polachek, A.
    Hirsch, D.
    Tzvetov, G.
    Grozinsky-Glasberg, S.
    Slutski, I.
    Singer, J.
    Weinstein, R.
    Shimon, I.
    Benbassat, C. A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (11) : 855 - 860
12345